Premium
Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statement
Author(s) -
Flerlage Jamie E.,
Kelly Kara M.,
Beishuizen Auke,
Cho Steve,
Alarcon Pedro A.,
Dieckmann Ute,
Drachtman Richard A.,
Hoppe Bradford S.,
Howard Scott C.,
Kaste Sue C.,
Kluge Regine,
Kurch Lars,
LandmanParker Judith,
Lewis Jocelyn,
Link Michael P.,
McCarten Kathleen,
Punnett Angela,
Stoevesandt Dietrich,
Voss Stephan D.,
Wallace William Hamish,
MauzKörholz Christine,
Metzger Monika L.
Publication year - 2017
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.26421
Subject(s) - medicine , harmonization , hodgkin lymphoma , lymphoma , identification (biology) , statement (logic) , medical physics , pathology , physics , botany , political science , acoustics , law , biology
International harmonization of staging evaluation and response criteria is needed for childhood, adolescence, and young adulthood Hodgkin lymphoma. Two Hodgkin lymphoma protocols from cooperative trials in Europe and North America were compared for areas in need of harmonization, and an evidence‐based approach is currently underway to harmonize staging and response evaluations with a goal to enhance comparisons, expedite identification of effective therapies, and aid in the approval process for new agents by regulatory agencies.